FindTrial
Sign In

The clinical observation of effects of adjuvant therapy on menstrual condition of patients with breast cancer

The clinical observation of effects of adjuvant therapy on menstrual condition of patients with breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCS-13003848
Enrollment
Unknown
Registered
2013-06-28
Start date
2013-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Case series:NA

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Female patients with breast cancer diagnosed by cytopahtology or histopathology; 2. Need to receive adjuvant chemotherapy or tamoxifen therapy; 3. Sign the informed consent form, and agree to receive follow-up.

Exclusion criteria

Exclusion criteria: 1. According to guidelines, no chemotherapy and hormonotherapy is needed; 2. Patients refused to refuse the clinical observation and follow-up.

Design outcomes

Primary

MeasureTime frame
estradiol;FSH;age;Menstrual Cycle;body mass index (BMI);—

Countries

China

Contacts

Public ContactZhang Bailin

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS)

bailin_zhang@hotmail.com+86 010 87788807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026